Source: International Congress 2014 – Clinical presentations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Priegnitz, S. Matthes, M. Treml, K. Richter, S. Stieglitz, W. J. Randerath (Solingen, Germany). Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey. Eur Respir J 2014; 44: Suppl. 58, 3580

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension Source: International Congress 2014 – Comorbidities Year: 2014 Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Clinical presentations Year: 2014 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Nutritional status in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators Source: International Congress 2014 – Clinical presentations Year: 2014 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Pulmonary hypertension in COPD: results from the ASPIRE registry Source: Eur Respir J 2013; 41: 1292-1301 Year: 2013 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016